HERCEPTIN (trastuzumab)
ANTINEOPLASTIC - HER2 INHIBITORS · HER2-POSITIVE CARCINOMA OF BREAST ·+2
GENENTECH
All drugs.
Search drugs by brand or generic name, or refine the directory by prescription status, class, indication, manufacturer, and specialty.
Enter at least 3 characters to search the full directory.
Results
TYKERB (lapatinib ditosylate)
HER2-POSITIVE CARCINOMA OF BREAST ·+1
GSK
PERJETA (pertuzumab)
ANTINEOPLASTIC - EGF RECEPTOR 2 (HER2) SUBDOMAIN II BLOCKER · HER2-POSITIVE CARCINOMA OF BREAST
GENENTECH
KADCYLA (ado-trastuzumab emtansine)
ANTINEOPLASTIC - HER2 INHIBITORS · HER2-POSITIVE CARCINOMA OF BREAST
GENENTECH
TYKERB (lapatinib ditosylate)
ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · HER2-POSITIVE CARCINOMA OF BREAST ·+1
Novartis Pharmaceuticals
NERLYNX (neratinib maleate)
ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · HER2-POSITIVE CARCINOMA OF BREAST
PUMA BIOTECHNOL
HERCEPTIN (trastuzumab)
ANTINEOPLASTIC - HER2 INHIBITORS · HER2-POSITIVE CARCINOMA OF BREAST ·+2
GENENTECH
HERCEPTIN HYLECTA (trastuzumab-hyaluronidase-oysk)
ANTINEOPLASTIC - HER2 INHIBITORS · HER2-POSITIVE CARCINOMA OF BREAST
GENENTECH
KANJINTI (trastuzumab-anns)
ANTINEOPLASTIC - HER2 INHIBITORS · HER2-POSITIVE CARCINOMA OF BREAST ·+2
AMGEN
OGIVRI (trastuzumab-dkst)
HER2-POSITIVE CARCINOMA OF BREAST ·+2
MYLAN INSTITUTI
TRAZIMERA (trastuzumab-qyyp)
ANTINEOPLASTIC - HER2 INHIBITORS · HER2-POSITIVE CARCINOMA OF BREAST ·+2
Parke-Davis Pfizer
HERZUMA (trastuzumab-pkrb)
ANTINEOPLASTIC - HER2 INHIBITORS · HER2-POSITIVE CARCINOMA OF BREAST ·+2
TEVA USA
ENHERTU (fam-trastuzumab deruxtecan-nxki)
ANTINEOPLASTIC - TOPOISOMERASE I INHIBITORS · HER2-POSITIVE CARCINOMA OF BREAST ·+5
DAIICHI SANKYO,
ONTRUZANT (trastuzumab-dttb)
HER2-POSITIVE CARCINOMA OF BREAST ·+2
Merck Sharp & Dohme
PHESGO (pertuzumab-trastuzumab-hyaluronidase-zzxf)
ANTINEOPLASTIC - HER2 INHIBITORS · HER2-POSITIVE CARCINOMA OF BREAST
GENENTECH
ONTRUZANT (trastuzumab-dttb)
ANTINEOPLASTIC - HER2 INHIBITORS · HER2-POSITIVE CARCINOMA OF BREAST ·+2
ORGANON LLC
OGIVRI (trastuzumab-dkst)
ANTINEOPLASTIC - HER2 INHIBITORS · HER2-POSITIVE CARCINOMA OF BREAST ·+2
BIOCON BIOLOGIC
LAPATINIB (lapatinib ditosylate)
ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · HER2-POSITIVE CARCINOMA OF BREAST ·+1
TEVA PHARM
LAPATINIB (lapatinib ditosylate)
ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · HER2-POSITIVE CARCINOMA OF BREAST ·+1
AVKARE
LAPATINIB (lapatinib ditosylate)
ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · HER2-POSITIVE CARCINOMA OF BREAST ·+1
LUPIN PHARMACEU
HERCESSI (trastuzumab-strf)
ANTINEOPLASTIC - HER2 INHIBITORS · HER2-POSITIVE CARCINOMA OF BREAST ·+2
ACCORD BIOPHARM
TYKERB (lapatinib ditosylate)
ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · HER2-POSITIVE CARCINOMA OF BREAST ·+1
Novartis Pharmaceuticals